Cargando…
Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
We describe a protocol for efficient generation of human‐induced pluripotent stem cells (hiPSCs) from urine‐derived cells (UDCs) obtained from adult donors using self‐replicative RNA containing the reprogramming factors OCT3/4, SOX2, KLF4, GLIS1, and c‐MYC (ReproRNA‐OKSGM). After electroporation, tr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540473/ https://www.ncbi.nlm.nih.gov/pubmed/32956580 http://dx.doi.org/10.1002/cpsc.124 |
_version_ | 1783591216596647936 |
---|---|
author | Bouma, Marga J. Arendzen, Christiaan H. Mummery, Christine L. Mikkers, Harald Freund, Christian |
author_facet | Bouma, Marga J. Arendzen, Christiaan H. Mummery, Christine L. Mikkers, Harald Freund, Christian |
author_sort | Bouma, Marga J. |
collection | PubMed |
description | We describe a protocol for efficient generation of human‐induced pluripotent stem cells (hiPSCs) from urine‐derived cells (UDCs) obtained from adult donors using self‐replicative RNA containing the reprogramming factors OCT3/4, SOX2, KLF4, GLIS1, and c‐MYC (ReproRNA‐OKSGM). After electroporation, transfection efficiency is quantified by measuring OCT3/4‐expressing UDCs using flow cytometry and should be ≥0.1%. hiPSC colonies emerge within 3 weeks after transfection and express multiple pluripotency markers. Moreover, the UDC‐derived hiPSCs are able to differentiate into cells of all three germ layers and display normal karyotypes. ReproRNA‐OKSGM is available commercially and only requires a single transfection step so that the protocol is readily accessible, as well as straightforward. In addition to a detailed step‐by‐step description for generating clonal hiPSCs from UDCs using ReproRNA‐OKSGM, we provide guidance for basic pluripotency characterization of the hiPSC lines. © 2020 The Authors. Basic Protocol: Reprogramming of urine‐derived cells using ReproRNA‐OKSGM Support Protocol 1: Determination of the pluripotency status of hiPSCs by flow cytometry Support Protocol 2: Characterization of functional pluripotency of hiPSCs |
format | Online Article Text |
id | pubmed-7540473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75404732020-10-09 Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation Bouma, Marga J. Arendzen, Christiaan H. Mummery, Christine L. Mikkers, Harald Freund, Christian Curr Protoc Stem Cell Biol Protocol We describe a protocol for efficient generation of human‐induced pluripotent stem cells (hiPSCs) from urine‐derived cells (UDCs) obtained from adult donors using self‐replicative RNA containing the reprogramming factors OCT3/4, SOX2, KLF4, GLIS1, and c‐MYC (ReproRNA‐OKSGM). After electroporation, transfection efficiency is quantified by measuring OCT3/4‐expressing UDCs using flow cytometry and should be ≥0.1%. hiPSC colonies emerge within 3 weeks after transfection and express multiple pluripotency markers. Moreover, the UDC‐derived hiPSCs are able to differentiate into cells of all three germ layers and display normal karyotypes. ReproRNA‐OKSGM is available commercially and only requires a single transfection step so that the protocol is readily accessible, as well as straightforward. In addition to a detailed step‐by‐step description for generating clonal hiPSCs from UDCs using ReproRNA‐OKSGM, we provide guidance for basic pluripotency characterization of the hiPSC lines. © 2020 The Authors. Basic Protocol: Reprogramming of urine‐derived cells using ReproRNA‐OKSGM Support Protocol 1: Determination of the pluripotency status of hiPSCs by flow cytometry Support Protocol 2: Characterization of functional pluripotency of hiPSCs John Wiley and Sons Inc. 2020-09-21 2020-12 /pmc/articles/PMC7540473/ /pubmed/32956580 http://dx.doi.org/10.1002/cpsc.124 Text en © 2020 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Protocol Bouma, Marga J. Arendzen, Christiaan H. Mummery, Christine L. Mikkers, Harald Freund, Christian Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation |
title | Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation |
title_full | Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation |
title_fullStr | Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation |
title_full_unstemmed | Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation |
title_short | Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation |
title_sort | reprogramming urine‐derived cells using commercially available self‐replicative rna and a single electroporation |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540473/ https://www.ncbi.nlm.nih.gov/pubmed/32956580 http://dx.doi.org/10.1002/cpsc.124 |
work_keys_str_mv | AT boumamargaj reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation AT arendzenchristiaanh reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation AT mummerychristinel reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation AT mikkersharald reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation AT freundchristian reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation |